共 34 条
[1]
Witztum J.L., The role of oxidized LDL in atherosclerosis’, Hypercholesterolemia, Hypo- Cholesterolcmia, Hypertriglyceridemia, pp. 353-365, (1990)
[2]
Yla-Herttuala S., Palinski W., Rosen-Feld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D., Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man, J Clin Invest, 84, pp. 1086-1095, (1989)
[3]
Boyd H.C., Gown A.M., Wolfbauer G., Chait A., Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipide- mic rabbit, Am J Pathol, 135, pp. 815-825, (1989)
[4]
Esterbauer H., Dieber-Rotheneder M., Striegl G., Wacg G., Role of vitamin E in preventing the oxidation of low-density lipoprotein, Am J Clin Nutr, 53, pp. 314S-321S, (1991)
[5]
Sato K., Niki E., Shimasaki H., Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C, Arch Biochem Bio- Phvs, 279, pp. 402-405, (1990)
[6]
Rcaven P.D., Parthasarathy S., Beltz W.F., Witztum J.L., Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against
[7]
n vitro oxidation in humans, Arterioscler Thromb, 12, pp. 318-324, (1992)
[8]
Morel D.W., Chisolm G.M., Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity, J Lipid Res, 30, pp. 1827-1834, (1989)
[9]
Nagano Y., Nakamura T., Matsuza-Wa Y., Cho M., Ueda Y., Kita T., Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit - Long-term antiatherogenic effect and effects on established plaques, Atherosclerosis, 92, pp. 131-140, (1992)
[10]
Williams R.J., Motteram J.M., Sharp C.H., Gallagher P.J., Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits, Atherosclerosis, 94, pp. 153-159, (1992)